The focus of this meeting was on human protection issues in clinical research. The group explored streamlined review mechanisms, central and regional IRBs, and identified suggestions for OHRP, FDA, and others that can facilitate this process.

The goal of this workshop is to understand how providers interact with the various components of the Clinical Research Enterprise, how the Enterprise can be improved, and to understand what the future vision of the Enterprise should be from the provider perspective.